What I am curious to understand is where the mismatch in expected goals or outcome was.
PAA clearly stated many times that stable disease was a good outcome. I assumed, wrongly it appears, that given Elancos apparent involvement in trial parameters that they would have shared that opinion.
It is now clear Elanco expected regression or at least a much larger trial number for stable disease. It seems this has come as a surprise for PAA.
How did the expectations become so mismatched, given Elancos apparent involvement in setting up the trial. Something doesn't add up.
- Forums
- ASX - By Stock
- PAA
- Ann: Elanco Option Update
Ann: Elanco Option Update, page-134
-
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
16.0¢ |
Change
-0.005(3.03%) |
Mkt cap ! $77.79M |
Open | High | Low | Value | Volume |
16.5¢ | 17.5¢ | 15.5¢ | $280.7K | 1.733M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 195397 | 16.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.5¢ | 43952 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 195397 | 0.160 |
3 | 421900 | 0.155 |
8 | 341333 | 0.150 |
4 | 157241 | 0.140 |
1 | 100000 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.165 | 43952 | 1 |
0.170 | 308280 | 4 |
0.175 | 559928 | 3 |
0.180 | 15000 | 1 |
0.185 | 493297 | 3 |
Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
Featured News
NEWS
Is oil undervalued?
PAA (ASX) Chart |